A B S T R A C T As a prerequisite to studies of whether the plasma membrane of the rat thymocyte contains specific, saturable binding sites for the thyroid hormone 3,5,3'-triiodothyronine (T3), a method was developed for the isolation of a plasma membrane fraction from these cells. As 
the plasma membrane of the rat thymocyte contains specific, saturable binding sites for the thyroid hormone 3,5,3'-triiodothyronine (T3), a method was developed for the isolation of a plasma membrane fraction from these cells. As judged from both electron microscopic and marker enzyme studies, the fraction was composed principally of plasma membrane vesicles, was free of nuclear contaminants, and was only slightly contaminated with other subcellular components. At 37°C and pH 7.4, binding of ['25I ]T3 by the fresh membrane preparation was rapid, reaching a maximum at 5 min and then declining with time, so that by 60 min binding was virtually nil. Decreased binding with time was due to a loss of functional binding sites, but did not reflect desensitization, since the decrease in binding activity with time was independent of the presence or absence of T3. Scatchard analysis of saturation studies revealed the presence of two binding sites, one with an apparent dissociation constant (Kd) of 0.95 nM and a maximum capacity of 5.3 X 1010 sites/100 ,ug protein, and the other with an apparent Kd of 25 nM and a binding capacity of 1.4 X 1012 sites/100 ,g protein. Measurement of calcium from the medium or by the addition of the beta adrenergic antagonist alprenolol. As judged from studies of the lower affinity binding site, these manipulations decreased the affinity, but not the number, of binding sites for T3. The relative potencies of thyronine analogues to inhibit the binding of ['25I]T3 were generally parallel to their previously reported potencies in stimulating the uptake of the sugar analogue 2-deoxy-glucose (2-DG) in intact rat thymocytes in vitro. Further, the inhibition of T3-binding produced by L-alprenolol or by excluding calcium from the medium resembled the previously reported inhibition that these manipulations produce with respect to T3-induced enhancement of 2-DG uptake. These findings suggest that the binding sites for T3 present in the plasma membrane of rat thymocytes act as functional receptors linked to the stimulation of 2-DG uptake that T3 induces in these cells. INTRODUCTION We have previously demonstrated that 3,5,3'-triiodothyronine (T3)' enhances the uptake of the glucose analogue 2-deoxy-D-glucose (2-DG) in rat thymocytes in vitro (1) . Several lines of evidence indicate that T3 induces its effect by acting at the level of the plasma membrane. Thus, the effect is rapid, is independent of new protein synthesis, and is mediated via an increase in cellular cyclic (c)AMP concentration, as a consequence of an increase in the activity of adenylate cyclase (2) (3) (4) , an enzyme that resides within the plasma membrane. Furthermore, epinephrine, which is known to initiate its action upon binding to its plasma membrane receptors and thence activating adenylate cyclase, produces with T3 a synergistic increase in the 2-DG uptake (5 At the end of the incubation period, triplicate 250-Ml aliquots of reaction mixture were quickly removed and applied onto 0.3-um Millipore filters (Millipore Corp., Bedford, MA) under vacuum. The membranes were then quickly washed three times with 2.5 ml of ice-cold buffer. The filters were then dried, transferred into tubes, and were counted in a gamma counter.
Kinetic parameters of T3 binding were obtained in saturation studies using Scatchard plots and the iterative technique described by Minneman (6) .
Electron microscopy. Plasma membrane fractions were prepared for examination under the electron microscope according to the technique described by Stemerman (7) . Cellular markers. DNA content in homogenates and membrane preparations was measured according to a method described by Burton (8); 5'-nucleotidase activity according to the method of Bosmann (9); succinate dehydrogenase activity by the method of Hatefi (10) ; Na+,K+-ATPase, activity by the method described by Wallach and Kamat (11) ; acid phosphatase activity by the method of Baudhuin (12); and glucose-6-phosphatase activity, as well as inorganic phosphate content, by methods described by Ames (13) .
. Purity of preparations of [1251]T3 was assessed by descending filter paper chromatography in a hexane-tertiary amyl alcohol-N-ammonia (1:10:11) solvent system according to a technique described by Borges et al. (14) .
Statistical analysis. The following statistical methods were used: Dunnet's test for comparisons between multiple groups and a single control; analysis of variance, followed by the Newman-Keuls multiple range test, for comparisons of multiple groups with each other; and analysis of covariance, followed by Dunnet's test, for comparisons of multiple regression lines with a single control line (15) .
RESULTS
Purity of plasma membrane preparations. Both ultramicroscopic appearance and biochemical markers indicated that plasma membrane preparations were highly purified. Electron microscopic studies revealed a homogenous plasma membrane preparation, comprising closed vesicles of varying sizes, ranging from 0.25 to 1.2 Mm Diam. Small quantities of ribosomes were present, but nuclear, mitochondrial, and lysosomal contaminants were not evident.
A comparison of the relative concentrations of specific cellular markers in the initial homogenates and the membrane preparations also indicated that the preparations were highly enriched in plasma membranes and were essentially devoid of other cellular components (Table I) . DNA content was virtually nil, indicating the absence of nuclei. The plasma membrane markers, 5'-nucleotidase and Na',K'-ATPase, were enriched by 15-and 12.5-fold, respectively. The preparation contained a small amount microsomes, as indicated by glucose-6-phosphatase; smaller amounts of mitochondria, as indicated by succinate dehydrogenase; and negligible amounts of lysosomes, as indicated by acid phosphatase. In terms of both the yield of protein (-0.43% of initial total protein) and of the relative enrichment of specific marker enzymes, the present preparations of rat thymocyte plasma membranes were quite comparable to those derived from thymocytes of calf and rabbit, as described by others (16) (17) (18) (19) (Table III) . This rank-order agreed quite closely with that of the potency of these agents to increase the uptake of 2-DG in the intact cell (1 EGTA to the calcium-free medium produced no further effect (Fig. 4) . In studies that examined binding of T3 to the low affinity site, omission of calcium was also found to decrease T3Lbinding. Scatchard analysis revealed this to be due to a reduction in the binding affinity, rather than the number of binding sites (Fig.  5) . Thus, as would be expected, the inhibitory effect of excluding calcium became proportionately less as the concentration of T3 was progressively increased.
Effect of L-alprenolol. Experiments to determine the effects of L-alprenolol on T3-binding were also conducted at tracer and at relatively high concentrations of T3, as in experiments with calcium-free medium. In the former experiments, L-alprenolol tartrate produced a dose-related inhibition of T3 binding (Fig. 4) . Sodium tartrate (0.1 mM) had no effect (data not shown). At the higher concentrations of T3, 10 ,M Lalprenolol was also inhibitory to T3 binding, and this effect, like that of excluding calcium, was to decrease the binding affinity, rather than the number of binding sites (Fig. 5) . Effect of epinephrine. Although epinephrine interacts synergistically with T3 to increase the uptake of 2-DG in intact rat thymocytes (2), epinephrine (0.1-100 ,uM) had no effect on the binding of tracer concentrations of [1251]T3 (data not shown).
DISCUSSION
In these studies we have demonstrated the presence of saturable binding sites for T3 and other thyroid hormones and analogues in plasma membrane preparations obtained from rat thymocytes. Saturable binding of T3 has been observed in nuclei or mitochondria from a variety of other tissues (20) (21) (22) (23) (24) . Nonetheless, the two T3 binding sites that we observed in our plasma membrane preparations cannot be ascribed to contamination of membrane preparations by those subcellular elements, since both electron microscopic and marker enzyme studies indicated that our preparations. were virtually devoid of mitochondria and were entirely devoid of nuclei.
Earlier studies have provided evidence of the existence of saturable binding sites for T3 in the plasma membranes of hepatocytes and fibroblasts (25) (26) (27) (28) . However, in the case of these T3 binding sites, there is no evidence that links them to a physiological response. Our interest in determining whether analogous T3-binding sites are present in the plasma membrane of the rat thymocyte stemmed from our previous observations in intact thymocytes, in which substantial evidence was obtained that the prompt increase in 2-DG uptake induced by T3 in vitro, as well as its synergistic interaction with epinephrine, is indicated at a plasma membrane level (1) (2) (3) (4) (5) .
Not only were saturable binding sites for T3 demonstrated, but several lines of inferential evidence were obtained linking the binding of T3 to these sites with the biochemical response mentioned above.
First, the apparent dissociation constants of the T3 binding sites found were in the range of concentrations at which T3 alone was found to be effective in increasing both cellular cyclic AMP concentration and 2-DG uptake in intact thymocytes (1, 3) . These concentrations are substantially higher than the assumed free T3 concentration in vivo (5-10 pM). However, 10 (27) , who found two classes of T3 binding site in plasma membranes of rat liver and kidney, though the affinities in these membranes was somewhat lower than those we found in the thymocyte plasma membrane.
Binding of T3 to the thymocyte plasma membrane was very prompt, reaching a maximum at 5 min and declining thereafter. Progressive (31) . With respect to the inhibitory effect of calcium, it is well known that plasma membranes have specific binding sites for calcium (32) (33) (34) and that calcium increases the binding of particular ligands to the plasma membranes of several tissues (35, 36) , but it is not known whether the binding of calcium initiates the latter responses.
